Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma.

Sun M, Cao Y, Okada R, Reyes-Gonzalez JM, Stack HG, Qin H, Li N, Seibert C, Kelly MC, Ruppin E, Ho M, Thiele CJ, Nguyen R
J Immunother Cancer. 2023 Jan;11(1):e005881. doi: 10.1136/jitc-2022-005881. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.